Rise in investment in regenerative medicine is fueling the specialty enzymes market size. Specialty enzymes play an important role in the field of regenerative medicine. They accelerate reactions and produce the desired target molecule in pharmaceuticals.
Increase in demand for non-toxic biological catalysts is driving the specialty enzymes industry expansion. Specialty enzymes are extensively used in research & biotechnology for DNA manipulation in vitro.
Key players in the global specialty enzymes market are developing robust products for use in the emerging regenerative medicine and advanced therapy markets. These superior specialty enzymes can help increase productivity and reduce the amount of raw materials needed to produce advanced therapies.
Specialty enzymes are proteins that can act as very specific biocatalysts to accelerate reactions and produce the desired target molecule in pharmaceuticals. These enzymes merge the advantages of a directing group controlling selectivity and a catalyst in a single reagent. Proteases, carbohydrases, and lipases are major types of specialty enzymes.
Specialty enzymes play a major role in the pharmaceutical sector as they help in combining molecules to produce new products or break them into smaller parts. They are employed in the manufacturing of APIs and other compounds. Specialty enzymes are also used in drug development due to their high specificity and affinity.
Rise in investment in cell and gene-based medicines is expected to spur the specialty enzymes market growth in the near future. Regenerative medicine and advanced therapy trials are gaining traction worldwide to improve disease outcomes. Specialty enzymes of the highest purity, specificity, and consistency are required in cell and gene therapy applications.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Specialty enzymes are used in the production of regenerative medicines as they offer higher stability, easier preparation, and lower cost than natural enzymes. Nanozymes are nanomaterials with intrinsic enzyme-like characteristics. They possess the magnetic, fluorescent, and electrical properties of nanomaterials. Thus, nanozymes can replace natural enzymes in the pharmaceutical sector.
Rapid development in nanozymes is propelling the specialty enzymes market demand. Nanozymes are employed in manufacturing regeneration medicines for use in targeted cancer therapy, diagnostic medicines, and bio-sensing. Regenerative medicine uses stem cells, tissue engineering, and other advanced therapies to replace or regenerate damaged tissues and organs.
In March 2024, Pandorum Technologies, a biotechnology company, closed a pre-Series B funding round to secure US$ 11 Mn in investment to advance its regenerative therapy for corneal blindness to the clinical phase. Hence, increase in investment in regenerative medicine is driving the specialty enzymes market value.
Biocatalysts are low-toxic and eco-friendly catalysts that reveal site- and enantioselectivity for specific substrates in various transformations. These catalysts place substrates in ideal positions to each other. This facilitates precise control of the reaction resulting in high chemo- and stereoselectivity.
Biocatalysts offer properties such as low toxicity, biodegradability, excellent selectivity, and good catalytic performance under mild reaction conditions. Thus, they are often regarded as green catalysts compared to conventional chemical catalysts in organic synthesis.
Rise in investment in molecular biology is boosting the specialty enzymes market revenue. In August 2022, Constructive Bio completed a US$ 15 Mn seed round and gained an exclusive license from the Medical Research Council to intellectual property (IP) developed by Professor Jason Chin’s Laboratory (The Chin Lab) at the MRC Laboratory of Molecular Biology (MRC-LMB).
Enzymes are used in molecular biology as catalysts in biochemical reactions. They accelerate chemical processes by providing a surface for reactions to occur.
According to the latest specialty enzymes market trends, the research & biotechnology application segment held largest share in 2023. Rise in investment in various biotechnologies is fueling the segment.
Polymerases & nucleases are widely employed in research & biotechnology for DNA manipulation in vitro, including DNA cloning, sequencing, labeling, and mutagenesis.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest specialty enzymes market analysis, North America accounted for the largest share in 2023. R&D of new specialty enzymes is fueling the market dynamics of the region.
Major pharmaceutical companies in North America are developing innovative and customized pharmaceutical materials that enable better medicines. They are collaborating to scale up processes in the tailored enzyme solutions market.
In November 2021, Novozymes collaborated with Novo Nordisk to combine their competencies and interests within the development of specialty enzymes for use in biopharma processing and regenerative medicines. Such strategies are increasing the specialty enzymes industry share in North America.
Vendors in the specialty enzymes market landscape are offering off-the-shelf products that have been developed using cutting-edge technology. These specialty enzymes are suitable for different chemical reactions.
Novonesis Group, Amano Enzyme Inc., Codexis, Inc., Advanced Enzymes Technologies Ltd., Thermo Fisher Scientific Inc., BBI Solutions, F. Hoffmann-La Roche Ltd., Biocatalysts, Amicogen, and American Laboratories, Inc. are key players operating in the specialty enzymes industry.
These companies have been profiled in the specialty enzymes market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 5.2 Bn |
| Market Forecast (Value) in 2034 | US$ 10.4 Bn |
| Growth Rate (CAGR) | 6.4% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 5.2 Bn in 2023
It is projected to grow at a CAGR of 6.4% from 2024 to 2034
Rise in investment in regenerative medicine and increase in demand for non-toxic biological catalysts
North America was the dominant region in 2023
Novonesis Group, Amano Enzyme Inc., Codexis, Inc., Advanced Enzymes Technologies Ltd., Thermo Fisher Scientific Inc., BBI Solutions, F. Hoffmann-La Roche Ltd., Biocatalysts, Amicogen, and American Laboratories, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Specialty Enzymes Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Specialty Enzymes Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Specialty Enzymes Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Proteases
6.3.2. Carbohydrases
6.3.3. Polymerases & Nucleases
6.3.4. Lipases
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Specialty Enzymes Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Research & Biotechnology
7.3.2. Diagnostics
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Specialty Enzymes Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Specialty Enzymes Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product, 2020-2034
9.3.1. Proteases
9.3.2. Carbohydrases
9.3.3. Polymerases & Nucleases
9.3.4. Lipases
9.3.5. Others
9.4. Market Value Forecast, by Application, 2020-2034
9.4.1. Research & Biotechnology
9.4.2. Diagnostics
9.4.3. Others
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By Country
10. Europe Specialty Enzymes Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2020-2034
10.3.1. Proteases
10.3.2. Carbohydrases
10.3.3. Polymerases & Nucleases
10.3.4. Lipases
10.3.5. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Research & Biotechnology
10.4.2. Diagnostics
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By Country/Sub-region
11. Asia Pacific Specialty Enzymes Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2020-2034
11.3.1. Proteases
11.3.2. Carbohydrases
11.3.3. Polymerases & Nucleases
11.3.4. Lipases
11.3.5. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Research & Biotechnology
11.4.2. Diagnostics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By Country/Sub-region
12. Latin America Specialty Enzymes Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2020-2034
12.3.1. Proteases
12.3.2. Carbohydrases
12.3.3. Polymerases & Nucleases
12.3.4. Lipases
12.3.5. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Research & Biotechnology
12.4.2. Diagnostics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Country/Sub-region
13. Middle East & Africa Specialty Enzymes Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2020-2034
13.3.1. Proteases
13.3.2. Carbohydrases
13.3.3. Polymerases & Nucleases
13.3.4. Lipases
13.3.5. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Research & Biotechnology
13.4.2. Diagnostics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. F. Hoffmann-La Roche Ltd.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Novonesis Group
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Amano Enzyme Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Codexis, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Advanced Enzymes Technologies Ltd.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Thermo Fisher Scientific Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. BBI Solutions
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Biocatalysts
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Amicogen
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. American Laboratories, Inc.
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Specialty Enzymes Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 04: North America Specialty Enzymes Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 05: North America Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 06: North America Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 07: Europe Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 09: Europe Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 10: Asia Pacific Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 12: Asia Pacific Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 13: Latin America Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 15: Latin America Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Middle East & Africa Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 18: Middle East & Africa Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2020-2034
List of Figures
Figure 01: Global Specialty Enzymes Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Specialty Enzymes Market Revenue (US$ Mn), by Product, 2023
Figure 03: Global Specialty Enzymes Market Value Share, by Product, 2023
Figure 04: Global Specialty Enzymes Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Specialty Enzymes Market Value Share, by Application, 2023
Figure 06: Global Specialty Enzymes Market Value Share, by Region, 2023
Figure 07: Global Specialty Enzymes Market Value (US$ Mn) Forecast, 2020-2034
Figure 08: Global Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 09: Global Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 10: Global Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 11: Global Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Figure 12: Global Specialty Enzymes Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Specialty Enzymes Market Attractiveness Analysis, by Region, 2024-2034
Figure 14: North America Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America Specialty Enzymes Market Attractiveness Analysis, by Country, 2024-2034
Figure 16: North America Specialty Enzymes Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 18: North America Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 19: North America Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 20: North America Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Figure 21: Europe Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 23: Europe Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 25: Europe Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 26: Europe Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 27: Europe Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Figure 28: Asia Pacific Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 30: Asia Pacific Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 32: Asia Pacific Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 33: Asia Pacific Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 34: Asia Pacific Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Latin America Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 37: Latin America Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 39: Latin America Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 40: Latin America Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 41: Latin America Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Figure 42: Middle East & Africa Specialty Enzymes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 44: Middle East & Africa Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Specialty Enzymes Market Value Share Analysis, by Product, 2023 and 2034
Figure 46: Middle East & Africa Specialty Enzymes Market Value Share Analysis, by Application, 2023 and 2034
Figure 47: Middle East & Africa Specialty Enzymes Market Attractiveness Analysis, by Product, 2024-2034
Figure 48: Middle East & Africa Specialty Enzymes Market Attractiveness Analysis, by Application, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Specialty Enzymes Market
*86 figures and 60 tables includes